Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology
- PMID: 25257029
- DOI: 10.1016/j.eururo.2014.08.079
Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology
Abstract
Background: Multiparametric magnetic resonance imaging (mp-MRI) is increasingly used in prostate cancer (CaP). Understanding the limitations of tumor detection, particularly in multifocal disease, is important in its clinical application.
Objective: To determine predictors of CaP detection by mp-MRI as confirmed by whole-mount histopathology.
Design, setting, and participants: A retrospective study was performed of 122 consecutive men who underwent mp-MRI before radical prostatectomy at a single referral academic center. A genitourinary radiologist and pathologist collectively determined concordance.
Outcome measurements and statistical analysis: The odds of tumor detection were calculated for clinical, MRI, and histopathologic variables using a multivariate logistic regression model.
Results and limitations: The 122 patients had 283 unique histologically confirmed CaP tumor foci. Gleason score was 6 in 21 (17%), 7 in 88 (72%), and ≥8 in 13 (11%) patients. Of the 122 cases, 44 (36%) had solitary and 78 (64%) had multifocal tumors. Overall mp-MRI sensitivity for tumor detection was 47% (132/283), with increased sensitivity for larger (102/141 [72%] >1.0 cm), higher-grade (96/134 [72%] Gleason ≥7) tumors, and index tumors (98/122 [80%]). Index tumor status, size, and prostate weight were significant predictors of detection in a multivariate analysis, and multifocality did not adversely impact detection of index tumors. A prostatectomy population was necessary by design, which may limit the ability to generalize these results.
Conclusions: Sensitivity for tumor detection increased with tumor size and grade. Index tumor status and tumor size were the strongest predictors of tumor detection, regardless of tumor focality. Some 80% of index tumors were detected, but nonindex tumor detection, even of high-grade lesions, was poor. These findings have important implications for focal therapy.
Patient summary: We evaluated the ability of magnetic resonance imaging (MRI) to detect cancer in patients undergoing prostatectomy. We found that tumor size and grade were important predictors of tumor detection, and although cancer is often multifocal, MRI is often able to detect the worst focus of cancer.
Keywords: Magnetic resonance imaging; Prostatectomy; Prostatic neoplasms.
Copyright © 2014. Published by Elsevier B.V.
Similar articles
-
Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.Eur Urol. 2019 May;75(5):712-720. doi: 10.1016/j.eururo.2018.11.031. Epub 2018 Dec 1. Eur Urol. 2019. PMID: 30509763
-
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19. Eur Urol. 2016. PMID: 26810346
-
Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.AJR Am J Roentgenol. 2015 Jul;205(1):W87-92. doi: 10.2214/AJR.14.13285. AJR Am J Roentgenol. 2015. PMID: 26102423 Free PMC article.
-
Understanding the pathological implications of MRI: application to focal therapy planning.Curr Opin Urol. 2015 May;25(3):198-204. doi: 10.1097/MOU.0000000000000166. Curr Opin Urol. 2015. PMID: 25768693 Review.
-
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review.Eur Urol Oncol. 2021 Aug;4(4):558-569. doi: 10.1016/j.euo.2020.08.003. Epub 2020 Aug 31. Eur Urol Oncol. 2021. PMID: 32883645 Review.
Cited by
-
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.J Nucl Med. 2016 Oct;57(Suppl 3):90S-96S. doi: 10.2967/jnumed.115.170175. J Nucl Med. 2016. PMID: 27694179 Free PMC article. Review.
-
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review.Cancer Manag Res. 2020 Jul 1;12:5225-5241. doi: 10.2147/CMAR.S250829. eCollection 2020. Cancer Manag Res. 2020. PMID: 32669872 Free PMC article. Review.
-
A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model.Cancer Res Commun. 2024 Mar 1;4(3):617-633. doi: 10.1158/2767-9764.CRC-23-0449. Cancer Res Commun. 2024. PMID: 38426815 Free PMC article.
-
How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?Int J Clin Oncol. 2020 Jan;25(1):175-186. doi: 10.1007/s10147-019-01524-9. Epub 2019 Aug 31. Int J Clin Oncol. 2020. PMID: 31473884
-
Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.Jpn J Radiol. 2019 Feb;37(2):154-164. doi: 10.1007/s11604-018-0801-9. Epub 2019 Jan 1. Jpn J Radiol. 2019. PMID: 30600483
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous